Concepedia

Kan He

KH

Statistics

Publications

5

Citations

980

H-Index

5

Active since

2007

Affiliations

Bristol-Myers Squibb (Germany)(Current)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Sweden)

Kan He is an author at Bristol-Myers Squibb (Germany) specializing in pharmacology, enzyme inhibition, and pharmacokinetics.

Publications per year

2007–2014

5

Publications

5

Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans

Nirmala Raghavan, Charles Frost, Zhigang Yu et al. · Drug Metabolism and Disposition · 2008 · 604 citations

, , +10

In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies

Lifei Wang, Donglu Zhang, Nirmala Raghavan et al. · Drug Metabolism and Disposition · 2009 · 252 citations

, , +17

Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor

Kan He, Joseph M. Luettgen, Donglu Zhang et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2011 · 97 citations

, , +8

Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modifications

Jennifer X. Qiao, Tammy C. Wang, Gren Z. Wang et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 17 citations · Full text

, , +15

Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moieties

Michael J. Orwat, Jennifer X. Qiao, Kan He et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 10 citations · Full text

, , +6

1–5 of 5